SB0226

Find a 2017 Bill:

2017 Regular Session

 

Entitled:

Biotechnology Investment Tax Credit - Qualified Maryland Biotechnology Company - Definition

Sponsored by:

Senator Manno

Status:

In the House - Hearing 3/22 at 1:00 p.m.


Synopsis:Altering the definition of "qualified Maryland biotechnology company" to extend a specified time period from a specified date that an active business may claim the biotechnology tax credit; altering the definition of "company" to include an entity that becomes duly organized and existing under specified laws for the purpose of conducting business for profit within 4 months of receiving a qualified investment; providing for the recapture of the credit; applying the Act; etc.
Analysis:Fiscal and Policy Note (Revised)
All Sponsors:Senators Manno, Edwards, Feldman, Hough, Kasemeyer, King, Lee, Madaleno, Peters, Serafini, Young, DeGrange, and McFadden
Additional Facts:Cross-filed with: HB0373
Introduced in a prior session as: SB1107 Session: 2016 Regular Session
Bill File Type: Regular
Effective Date(s): June 1, 2017
Committee(s):
Budget and Taxation  View Committee HearingWays and Means  View Committee Hearing
Broad Subject(s):Taxes - Income
Narrow Subject(s):Industry and Technology
Investments -see also- Securities
Tax Credits
Statutes:Article - Tax - General
(10-725)

How a Bill Becomes Law

Legislative Lingo

Explanation of Floor Motions and Actions


March 22, 2017 3:17 P.M.